Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Apply
Precem-TcT & FTD-TPI
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step